These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 25792807)

  • 1. Neuroprotective therapies for glaucoma.
    Song W; Huang P; Zhang C
    Drug Des Devel Ther; 2015; 9():1469-79. PubMed ID: 25792807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The dawn of neuroprotective therapy for glaucomatous optic neuropathy].
    Yamamoto T
    Nippon Ganka Gakkai Zasshi; 2001 Dec; 105(12):866-83. PubMed ID: 11802458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease progression and the need for neuroprotection in glaucoma management.
    Varma R; Peeples P; Walt JG; Bramley TJ
    Am J Manag Care; 2008 Feb; 14(1 Suppl):S15-9. PubMed ID: 18284311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Retinal ganglion cells death in glaucoma--mechanism and potential treatment. Part I].
    Rokicki W; Dorecka M; Romaniuk W
    Klin Oczna; 2007; 109(7-9):349-52. PubMed ID: 18260296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective Strategies in Glaucoma.
    Gossman CA; Christie J; Webster MK; Linn DM; Linn CL
    Curr Pharm Des; 2016; 22(14):2178-92. PubMed ID: 26818878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An experimental basis for implicating excitotoxicity in glaucomatous optic neuropathy.
    Vorwerk CK; Gorla MS; Dreyer EB
    Surv Ophthalmol; 1999 Jun; 43 Suppl 1():S142-50. PubMed ID: 10416757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Aiming for zero blindness].
    Nakazawa T
    Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translational Pharmacology in Glaucoma Neuroprotection.
    Levin LA
    Handb Exp Pharmacol; 2017; 242():209-230. PubMed ID: 27752844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of retinal ganglion cell damage in glaucomatous optic neuropathy: Axon transport, injury and soma loss.
    Nuschke AC; Farrell SR; Levesque JM; Chauhan BC
    Exp Eye Res; 2015 Dec; 141():111-24. PubMed ID: 26070986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotection in glaucoma: a model for neuroprotection in optic neuropathies.
    Marcic TS; Belyea DA; Katz B
    Curr Opin Ophthalmol; 2003 Dec; 14(6):353-6. PubMed ID: 14615639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and emerging medical therapies in the treatment of glaucoma.
    Bagnis A; Papadia M; Scotto R; Traverso CE
    Expert Opin Emerg Drugs; 2011 Jun; 16(2):293-307. PubMed ID: 21406029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current and emerging medical therapies for glaucoma.
    Tsai JC; Kanner EM
    Expert Opin Emerg Drugs; 2005 Feb; 10(1):109-18. PubMed ID: 15757407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptin as a neuroprotective agent in glaucoma.
    Gupta A
    Med Hypotheses; 2013 Nov; 81(5):797-802. PubMed ID: 24035688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Glaucoma as primary optic neuropathy].
    Nicolae A; Stefan C
    Oftalmologia; 2001; 54(4):5-8. PubMed ID: 12035602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma.
    Hains BC; Waxman SG
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4164-9. PubMed ID: 16249495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of the site of injury of glaucoma to neuroprotective strategies.
    Levin LA
    Surv Ophthalmol; 2001 May; 45 Suppl 3():S243-9; discussion S273-6. PubMed ID: 11377443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective therapies in glaucoma: I. Neurotrophic factor delivery.
    Nafissi N; Foldvari M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016; 8(2):240-54. PubMed ID: 26306832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should we treat the brain in glaucoma?
    Gupta N; Yücel YH
    Can J Ophthalmol; 2007 Jun; 42(3):409-13. PubMed ID: 17508036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotection in relation to retinal ischemia and relevance to glaucoma.
    Osborne NN; Ugarte M; Chao M; Chidlow G; Bae JH; Wood JP; Nash MS
    Surv Ophthalmol; 1999 Jun; 43 Suppl 1():S102-28. PubMed ID: 10416754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and cell-based approaches for neuroprotection in glaucoma.
    Lebrun-Julien F; Di Polo A
    Optom Vis Sci; 2008 Jun; 85(6):417-24. PubMed ID: 18521011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.